Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial

Go back to Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial
Pfizer Inc. (NYSE: PFE) Delayed: 28.07 -0.17 (0.6%)
Previous Close $28.24    52 Week High $37.39 
Open $28.00    52 Week Low $28.25 
Day High $28.16    P/E 17.01 
Day Low $27.65    EPS $1.65 
Volume 14,943,176